These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 21097507)
1. Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway. Qian X; Zhang J; Liu J J Biol Chem; 2011 Jan; 286(3):2111-20. PubMed ID: 21097507 [TBL] [Abstract][Full Text] [Related]
2. [Production and mechanism of CCL5 by macrophages in U14 cervical cancer-bearing mice during infection]. Ren H; Ren G; Sun L; Fan X; Wang Y; Li X Zhonghua Fu Chan Ke Za Zhi; 2015 May; 50(5):367-73. PubMed ID: 26311457 [TBL] [Abstract][Full Text] [Related]
3. The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner. Avni D; Philosoph A; Meijler MM; Zor T Immunology; 2010 Mar; 129(3):375-85. PubMed ID: 19922425 [TBL] [Abstract][Full Text] [Related]
4. Effects of mechanical strain on the function of Gap junctions in osteocytes are mediated through the prostaglandin EP2 receptor. Cherian PP; Cheng B; Gu S; Sprague E; Bonewald LF; Jiang JX J Biol Chem; 2003 Oct; 278(44):43146-56. PubMed ID: 12939279 [TBL] [Abstract][Full Text] [Related]
5. Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes. Goldmann O; Hertzén E; Hecht A; Schmidt H; Lehne S; Norrby-Teglund A; Medina E J Immunol; 2010 Aug; 185(4):2372-81. PubMed ID: 20644176 [TBL] [Abstract][Full Text] [Related]
6. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Qian X; Gu L; Ning H; Zhang Y; Hsueh EC; Fu M; Hu X; Wei L; Hoft DF; Liu J J Immunol; 2013 Jun; 190(11):5894-902. PubMed ID: 23645882 [TBL] [Abstract][Full Text] [Related]
7. Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B. Chen BC; Liao CC; Hsu MJ; Liao YT; Lin CC; Sheu JR; Lin CH J Immunol; 2006 Jul; 177(1):681-93. PubMed ID: 16785567 [TBL] [Abstract][Full Text] [Related]
16. IFN-gamma activates cAMP/PKA/CREB signaling pathway in murine peritoneal macrophages. Liu L; Wang Y; Fan Y; Li CL; Chang ZL J Interferon Cytokine Res; 2004 Jun; 24(6):334-42. PubMed ID: 15212707 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 inhibits advanced glycation end product-induced adhesion molecule expression, cytokine production, and lymphocyte proliferation in human peripheral blood mononuclear cells. Takahashi HK; Liu K; Wake H; Mori S; Zhang J; Liu R; Yoshino T; Nishibori M J Pharmacol Exp Ther; 2009 Nov; 331(2):656-70. PubMed ID: 19700629 [TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A. Iwahashi H; Takeshita A; Hanazawa S J Immunol; 2000 May; 164(10):5403-8. PubMed ID: 10799905 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. Takayama K; García-Cardena G; Sukhova GK; Comander J; Gimbrone MA; Libby P J Biol Chem; 2002 Nov; 277(46):44147-54. PubMed ID: 12215436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]